AURA

Aura Biosciences (AURA)

Aura Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AURA

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	20:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AURA	Aura Biosciences Inc
2024/05/09	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AURA	Aura Biosciences Inc
2024/05/09	20:00	GlobeNewswire Inc.	Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:AURA	Aura Biosciences Inc
2024/05/08	20:00	GlobeNewswire Inc.	Aura Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:AURA	Aura Biosciences Inc
2024/03/27	20:00	Business Wire	Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	NASDAQ:AURA	Aura Biosciences Inc
2024/03/05	07:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/02/26	21:00	Business Wire	Aura Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:AURA	Aura Biosciences Inc
2024/02/24	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/02/03	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/02/03	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/02/03	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/01/25	06:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/01/25	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/01/25	06:01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/01/25	06:01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/01/09	06:11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2024/01/08	21:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AURA	Aura Biosciences Inc
2024/01/03	06:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2023/12/16	06:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2023/12/07	22:00	Business Wire	Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma	NASDAQ:AURA	Aura Biosciences Inc
2023/11/10	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2023/11/10	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AURA	Aura Biosciences Inc
2023/11/10	06:05	Business Wire	Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights	NASDAQ:AURA	Aura Biosciences Inc
2023/11/08	21:00	Business Wire	Aura Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:AURA	Aura Biosciences Inc
2023/11/08	08:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2023/11/08	08:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AURA	Aura Biosciences Inc
2023/11/08	06:55	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:AURA	Aura Biosciences Inc
2023/11/07	12:02	Business Wire	Aura Biosciences Announces Pricing of Public Offering of Common Stock	NASDAQ:AURA	Aura Biosciences Inc
2023/11/07	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc
2023/11/07	06:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AURA	Aura Biosciences Inc